Branchenvergleich
|
| Boston Scient... | Edwards Lifes... | Becton, Dicki... | IDEXX Laborat... | Nasdaq 100 |
Überblick
|
|
ISIN
|
| US1011371077 | US28176E1082 | US0758871091 | US45168D1046 | US6311011026 |
Marktkapitalisierung
|
|
133,61 Mrd. EUR | 38,01 Mrd. EUR | 59,89 Mrd. EUR | 31,45 Mrd. EUR | - |
Anzahl d. umlauf. Aktien
|
|
1,48 Mrd. | 587,9 Mio. | 287,14 Mio. | 81,33 Mio. | - |
Dividende je Aktie*
|
|
- | - | 3,80 USD | - | - |
Dividendenrendite
|
|
- | - | 1,67% | - | - |
KGV
|
|
78,49 | 10,12 | 38,75 | 39,22 | - |
KGV (mit verwäss. Erg. / Aktie)*
|
|
71,46 | 10,62 | 41,14 | 38,75 | - |
Streubesitz
|
|
- | 83,04% | 77,40% | 57,24% | - |
Performance
|
|
Börse
|
| NYSE | NYSE | NYSE | NASDAQ | Indices Nasdaq |
1 Woche
|
|
+3,54% | +3,28% | +1,29% | -1,01% | +2,25% |
1 Monat
|
|
-6,12% | -6,66% | +1,20% | -5,95% | -10,61% |
3 Monate
|
|
+12,35% | -2,99% | +1,67% | +2,82% | -6,59% |
lfd. Jahr
|
|
+10,73% | -4,59% | +0,42% | +2,16% | -5,71% |
1 Jahr
|
|
+47,09% | -23,93% | -4,16% | -20,28% | +10,16% |
3 Jahre
|
|
+123,65% | -37,37% | -10,82% | -22,14% | +37,39% |
5 Jahre
|
|
+263,07% | +22,38% | -0,44% | +105,90% | +176,12% |
Fundamentalkennzahlen
|
| 2024 | 2024 | 2024 | 2024 | - |
Rechnungslegung
|
| US GAAP | US GAAP | US GAAP | US GAAP | - |
Umsatzerlöse
(in Mio.)
|
|
16.747 USD | 5.439,5000 USD | 20.178 USD | 3.897,5040 USD | - |
Umsatzwachstum
|
|
17,61% | -9,41% | 4,16% | 6,46% | - |
EBITDA
(in Mio.)
|
|
- | - | - | - | - |
Betriebsergebnis
(in Mio.)
|
|
2.603 USD | 1.378,7000 USD | 2.397 USD | 1.128,3370 USD | - |
Ergebnis vor Steuern
(in Mio.)
|
|
2.282 USD | 1.548,1000 USD | 2.005 USD | 1.109,8310 USD | - |
Konzernjahresüberschuss
(in Mio.)
|
|
1.853 USD | 4.174,6000 USD | 1.705 USD | 887,8670 USD | - |
Gewinnwachstum
|
|
18,03% | 197,68% | 19,73% | 5,07% | - |
Ergebnis je Aktie
|
|
1,26 USD | 6,98 USD | 5,88 USD | 10,77 USD | - USD |
Eigenkapital
(in Mio.)
|
|
22.003 USD | 10.062,9000 USD | 25.890 USD | 1.595,3130 USD | - |
Eigenkapitalquote
|
|
55,85% | 77,08% | 45,19% | 48,44% | - |
Eigenkapitalrendite
|
|
8,42% | 41,49% | 6,59% | 55,65% | - |
Buchwert je Aktie
|
|
14,91 USD | 17,12 USD | 89,55 USD | 19,62 USD | - |
Aktiva, gesamt
(in Mio.)
|
|
39.395 USD | 13.055,3000 USD | 57.286 USD | 3.293,4430 USD | - |
Gesamtkapitalrendite
|
|
4,70% | 31,98% | 2,98% | 26,96% | - |
Cash Flow (lauf. Geschäft.)
(in Mio.)
|
|
3.435 USD | 542,3000 USD | 3.844 USD | 929,0010 USD | - |
* Letztes Geschäftsjahr